Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neurotez Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10807
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurotez Inc (Neurotez) is a biotechnology company that develops and markets leptin product, a novel hormone replacement therapy for Alzheimer’s disease (AD). The company’s product pipeline includes leptin, NT1, NT2, and others. Its product leptin is an adipocyte hormone that controls energy homeostasis and is used for the treatment of Alzheimer’s disease. Neurotez also develops a novel protein-protein interaction in a subset of familial cases of early onset Alzheimer’s disease and discovers CNS drugs. The company uses the screening methodology to identify the protein-protein interactions and novel protein targets for the drug development. Neurotez is headquartered in Bridgewater, New Jersey, the US.

Neurotez Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neurotez Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurotez Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Neurotez Partners with KineMed 10
Licensing Agreements 11
Neurotez Enters into Licensing Agreement with GCA Therapeutics to Develop Leptin Derivatives 11
Equity Offering 12
Neurotez to Raise up to USD7 Million in Private Placement of Shares 12
Neurotez Inc – Key Competitors 13
Neurotez Inc – Key Employees 14
Neurotez Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Neurotez Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Neurotez Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurotez Partners with KineMed 10
Neurotez Enters into Licensing Agreement with GCA Therapeutics to Develop Leptin Derivatives 11
Neurotez to Raise up to USD7 Million in Private Placement of Shares 12
Neurotez Inc, Key Competitors 13
Neurotez Inc, Key Employees 14

List of Figures
Neurotez Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hitachi Metals, Ltd.:企業の戦略・SWOT・財務情報
    Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Riviera Holdings Corp.:企業の戦略・SWOT・財務分析
    SummaryRiviera Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • PT Indofarma (Persero) Tbk (INAF):企業概要、財務及び戦略的SWOT分析
    Summary Pt Indofarma (Persero) Tbk (Indofarma) is a pharmaceutical company. The company manufactures, markets and distributes ethical and over-the counter, diagnostic and other medicines. It offers products in the areas of analgesic, anti helmenthic, anti asthma, anti diarrhea, anti influenza, anti …
  • PSR Group BV:製薬・医療:M&Aディール及び事業提携情報
    Summary PSR Group BV (PSR) is a contract research and staffing consultancy service provider. The company operates through two divisions such as PSR Orphan Experts and PSR Pharma Resource. Its PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. The com …
  • RCS MediaGroup S.p.A. (RCS):企業の財務・戦略的SWOT分析
    RCS MediaGroup S.p.A. (RCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Hookipa Biotech AG (Hookipa) is a biotechnology company that develops vaccines and next-generation immunotherapeutics for the prevention and treatment of cancer and infectious diseases. The company's lead product candidate include HB101 vaxwave, a vaccine under development for immunization a …
  • Progenity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Newcrest Mining Ltd:企業の戦略・SWOT・財務情報
    Newcrest Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Newcrest Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Systar (SAR):企業概要、財務及び戦略的SWOT分析
    Summary Systar is an information technology company. The company designs, develops, and markets performance management software for large organizations that maximize the efficiency of the business operations and IT infrastructure. Its Omni Vision division offers OmniVision for VMware, OmniVision for …
  • Bank Hapoalim B.M.:企業の戦略・SWOT・財務分析
    SummaryBank Hapoalim B.M. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Komipharm International Co., Ltd. (041960)(製薬・医療分野):企業M&A動向
    Summary Komipharm International Co., Ltd. (Komipharm) is a pharmaceutical company. The company manufactures and supplies veterinary vaccines, veterinary pharmaceuticals, natural extract food additives and bio-fertilizers. Its chemical products include antibiotics, nutrients, disinfectant and other c …
  • Vorwerk and Co. KG:企業の戦略・SWOT・財務分析
    SummaryVorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Schwarz Beteiligungs GmbH:企業の戦略・SWOT・財務分析
    SummarySchwarz Beteiligungs GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Covea Insurance plc:企業の戦略・SWOT・財務情報
    Covea Insurance plc - Strategy, SWOT and Corporate Finance Report Summary Covea Insurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eskom Holdings SOC Limited:企業の戦略的SWOT分析
    Eskom Holdings SOC Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Gran Tierra Energy Inc.:企業のM&A・提携・投資分析
    Gran Tierra Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gran Tierra Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Nitinol Devices and Components, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Nitinol Devices and Components, Inc. (NDC) is a medical device company that manufactures and markets Nitinol devices. The company’s products include wire, strip, sheet, tubing, and bar. Its products are used in therapeutic areas such as endovascular, peripheral vascular, orthopedic and neuro …
  • Sequella, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Sequella, Inc. (Sequella) is a biopharmaceutical company. The company develops and commercializes products for diagnosis and treatment of infectious diseases. Its antibiotic pipeline includes tuberculosis, C.difficile infections and crohn’s disease. Sequella develop therapies for infections …
  • Monex Group, Inc.:企業の戦略・SWOT・財務情報
    Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆